Tudo o que você precisa
saber sobre os diferentes tipos de hepatite, que pode levar à morte
A hepatite é a inflamação do fígado e é a segunda maior doença
infecciosa letal do mundo - Getty Images
A hepatite é a inflamação do fígado e é a segunda maior doença
infecciosa letal do mundo Imagem: Getty Images
Renata Turbiani - De São Paulo para a BBC News Brasil
31/07/2019 05h29
Todos os anos, segundo a Organização Mundial da Saúde (OMS), as
hepatites virais causam 1,7 milhão de mortes no mundo.
No Brasil, entre 1999 a 2018, foram registrados 632.814 casos da doença.
Desse total, 167.108 (26,4%) foram do tipo A, 233.027 (36,8%) do B,
228.695 (36,1%) do C e 3.984 (0,7%) do ... - Veja mais em
https://noticias.uol.com.br/ultimas-noticias/bbc/2019/07/31/tudo-o-que-voce-precisa-saber-sobre-os-diferentes-tipos-de-hepatite-que-pode-levar-a-morte.htm?cmpid=copiaecola
Tudo o que você precisa
saber sobre os diferentes tipos de hepatite, que pode levar à morte
A hepatite é a inflamação do fígado e é a segunda maior doença
infecciosa letal do mundo - Getty Images
A hepatite é a inflamação do fígado e é a segunda maior doença
infecciosa letal do mundo Imagem: Getty Images
Renata Turbiani - De São Paulo para a BBC News Brasil
31/07/2019 05h29
Todos os anos, segundo a Organização Mundial da Saúde (OMS), as
hepatites virais causam 1,7 milhão de mortes no mundo.
No Brasil, entre 1999 a 2018, foram registrados 632.814 casos da doença.
Desse total, 167.108 (26,4%) foram do tipo A, 233.027 (36,8%) do B,
228.695 (36,1%) do C e 3.984 (0,7%) do ... - Veja mais em
https://noticias.uol.com.br/ultimas-noticias/bbc/2019/07/31/tudo-o-que-voce-precisa-saber-sobre-os-diferentes-tipos-de-hepatite-que-pode-levar-a-morte.htm?cmpid=copiaecola
quinta-feira, 10 de maio de 2018
Liver-destroying virus may have been with us since the dawn of civilization
The liver-destroying hepatitis B virus (HBV) kills nearly a
million people each year. Now, a pair of new genetic studies suggests
the pathogen has been with us at least since the dawn of civilization.
Until now, the oldest evidence for HPV was a strain discovered in a 16th century Italian mummy.
In the new work, a team led by geneticist Eske Willerslev of the
University of Cambridge in the United Kingdom sequenced the whole
genomes of 304 people found at archaeological sites throughout Eurasia,
most dating to the Bronze and Iron ages (approximately 3500 B.C.E.
through 500 B.C.E.). They quickly recognized the genetic signature of
HBV in 12 individuals. The oldest sample, from a man, was about 4500
years old and found in an ancient grave in Osterhofen, Germany.
The team then compared the DNA sequences of these ancient viruses
with modern versions of HBV and used advanced mathematical modeling
techniques to estimate how long it would take for these variations to
arise given their prevalence in populations through time. The data
revealed that the virus likely originated roughly between 13,600 B.C.E. and 9600 B.C.E., they report today in Nature.
Another study led by geneticist Johannes Krause at the Max Planck
Institute for the Science of Human History in Jena, Germany, found traces of HBV in the dental pulp of three skeletons from Germany
dating from 3200 B.C.E. to 5000 B.C.E. Considering the results of both
studies, “[HBV] seems to have been pretty common in the past,” says
Krause, whose team reported its work earlier this week in a paper
published to the bioRxiv preprint server. That’s not necessarily a
surprise, he says, but it points the way for future researchers to
investigate other ancient diseases.
One popular hypothesis, based on the fact that chimpanzees and
gorillas have strains of HBV extremely similar to humans, has suggested
the virus may have arisen in Africa, then jumped into humans through
blood-to-blood contact during hunting or cutting their meat. From there,
the virus could have proliferated into different strains as humans
filtered out into Eurasia about 80,000 to 120,000 years ago.
Willerslev’s team’s findings suggest an intriguing alternate
possibility: that HBV may have arisen much more recently in humans
living in Eurasia or even North America, then was transmitted to both
humans and nonhuman primates in Africa, although the mechanism of such a
transmission is murky. This timeline dovetails with the beginnings of
human civilization, when larger populations and trade routes would have
helped the disease spread and transform into novel strains.
Krause, however, is skeptical about estimates of when the virus
arose. HBV recombines genetic material from its host, so typical
molecular dating techniques based on rates of genetic mutation don’t
work, he says.
Hendrik Poinar, an evolutionary geneticist at McMaster University in
Hamilton, Canada, who wasn’t involved in the research, agrees that these
limitations make it difficult to speculate on the chronological origins
of the virus given current data. “Saying anything about the timing of
HBV’s origins is dicey at this point.”
But regardless of HBV’s age, “These papers show really beautifully
that you can find samples of pathogens in DNA that is thousands of years
old,” he says. “This virus’s interaction with humans is a dynamic that
has been playing out over millennia.”